Expression of androgen receptors and inhibin/activin α and βA subunits in breast apocrine lesions

APMIS

Volumn 114, Issue 5, 2006, Pages 352-358

  Shim, Hyo Sub ^a,c   Jung, Woo Hee ^a,c   Kim, Haeryoung ^a,c   Park, Kyeongmee ^b   Cho, Nam Hoon ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Pathology ^*  (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Activin; Androgen receptor; Apocrine lesion; Breast; Inhibin

Indexed keywords

ACTIN ALPHA; ACTIVIN; ACTIVIN BETA A; ANDROGEN RECEPTOR; INHIBIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; BREAST PAPILLOMA; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROCYSTIC BREAST DISEASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

APOCRINE GLANDS; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; INHIBINS; METAPLASIA; PAPILLOMA, INTRADUCTAL; RECEPTORS, ANDROGEN; SWEAT GLAND NEOPLASMS;

EID: 33744803728     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_321.x     Document Type: Article

References (20)

1. Miller WR Telford J Dixon JM Shivas AA. Androgen metabolism and apocrine differentiation in human breast cancer. Breast Cancer Res Treat 1985 5:67 73.
2. Gatalica Z. Immunohistochemical analysis of apocrine breast lesion: consistent overexpression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 1997 193:753 8.
3. Eusebi V Damiani S Losi L Millis RR. Apocrine differentiation in breast epithelium. Adv Anat Pathol 1997 4:139 55.
4. Selim AGA Wells CA. Immunohistochemical localization of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 1999 52:838 41.
5. Leal C Henrique R Monteiro P Lopes C Bento MJ Sousa CPD, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol 2001 32:487 93.
6. Tavassoli FA Purcell CA Bratthauer GL Man Y. Androgen receptor expression along with the loss of bcl-2, ER and PR expression in benign and malignant apocrine lesions of the breast: implications for therapy. Breast J 1996 2:261 9.
7. Vale W Rivier C Hsueh A Campen C Meunier H Bicsak T, et al. Chemical and biochemical characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1988 44:1 34.
8. Ueno N Nishimatsu S Murakami K. Activin as a cell differentiation factor. Prog Growth Factor Res 1990 2:113 24.
9. Meunier H Rivier C Evans RM Vale W. Gonadal and extragonadal expression of inhibin α, βA, and βB subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 1988 85:247 51.
10. Robinson GW Hennighausen L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 1997 124:2701 8.
11. Liu QY Niranjan B Gomes P Gomm JJ Davies D Coombes RC, et al. Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 1996 56:1155 63.
12. de Winter JP Roelen AJ ten Dijke P van der Burg B van den Eijnden-van Raaij AJ. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF- β1) induced growth inhibition and transcriptional response in breast tumor cells. Oncogene 1997 14:1891 9.
13. Loreto CD Reis FM Cataldi P Zuiani C Luisi S Beltrami CA, et al. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 1999 141:190 4.
14. Hsueh AJW Dahl KD Vaughan J Tucker E Rivier J Bardin CW, et al. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA 1987 84:5082 6.
15. Thike AA Chang MJ Fook-Chong S Tan PH. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 2001 33:21 5.
16. Japaze H Emina J Diaz C Schwam RJ Gercovich N Demonty G, et al. Pure invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast 2005 14:3 10.
17. Bratthauer GL Lininger RA Man Y Tavassoli FA. Androgen and estrogen receptor mRNA status in apocrine carcinomas. Diag Mol Pathol 2002 11:113 8.
18. Takeuchi H Tsuji K Ueo H Kano T Maehara Y. Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women. Breast Cancer Res Treat 2004 88:49 54.
19. Ying SY Zhang Z. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line. Breast Cancer Res Treat 1996 37:151 60.
20. Zhang Z Zhao Y Batres Y Lin MF Ying SY. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP. Biochem Biophys Res Commun 1997 234:362 5.